Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gitomer

Showing results (161-170 of 180) with videos related to

Pageof 18
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|February 19, 2025
Overweight Status, Obesity, and Progression to ESKD in Patients with Autosomal Dominant Polycystic Kidney DiseaseKristen L Nowak, Timothy P Copeland, Elaine Ku, et al.
Contemporary Clinical Trials|December 27, 2023
Statin therapy in patients with early-stage autosomal dominant polycystic kidney disease: Design and baseline characteristicsBerenice Y Gitomer, Wei Wang, Diana George, et al.
Kidney International Reports|May 14, 2023
OVERTURE: A Worldwide, Prospective, Observational Study of Disease Characteristics in Patients With ADPKDRonald D Perrone, Dorothee Oberdhan, John Ouyang, et al.
Kidney Medicine|August 17, 2021
Pain and Obesity in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) StudiesKristen L Nowak, Kaleigh Murray, Zhiying You, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 11, 2026
Renal blood flow and progression to kidney failure in ADPKDKristen L Nowak, Timothy P Copeland, Elaine Ku, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 20, 2015
Therapeutic Area Data Standards for Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC)Ronald D Perrone, Jon Neville, Arlene B Chapman, et al.
Kidney International|September 14, 2020
Mineral bone disease in autosomal dominant polycystic kidney diseaseBerenice Gitomer, Renata Pereira, Isidro B Salusky, et al.
Kidney International Reports|December 18, 2019
Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease PatientsMark R Hanudel, Isidro B Salusky, Renata C Pereira, et al.
Kidney International Reports|January 10, 2022
<i>PKD1</i> Compared With <i>PK</i> <i>D2</i> Genotype and Cardiac Hospitalizations in the Halt Progression of Polycystic Kidney Disease StudiesCortney Steele, Zhiying You, Berenice Y Gitomer, et al.
Kidney International|September 26, 2018
CD8<sup>+</sup> T cells modulate autosomal dominant polycystic kidney disease progressionEmily K Kleczko, Kenneth H Marsh, Logan C Tyler, et al.
Pageof 18

Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
Clinical Journal of the American Society of Nephrology : CJASN|February 19, 2025
Overweight Status, Obesity, and Progression to ESKD in Patients with Autosomal Dominant Polycystic Kidney DiseaseKristen L Nowak, Timothy P Copeland, Elaine Ku, et al.
Contemporary Clinical Trials|December 27, 2023
Statin therapy in patients with early-stage autosomal dominant polycystic kidney disease: Design and baseline characteristicsBerenice Y Gitomer, Wei Wang, Diana George, et al.
Kidney International Reports|May 14, 2023
OVERTURE: A Worldwide, Prospective, Observational Study of Disease Characteristics in Patients With ADPKDRonald D Perrone, Dorothee Oberdhan, John Ouyang, et al.
Kidney Medicine|August 17, 2021
Pain and Obesity in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) StudiesKristen L Nowak, Kaleigh Murray, Zhiying You, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 11, 2026
Renal blood flow and progression to kidney failure in ADPKDKristen L Nowak, Timothy P Copeland, Elaine Ku, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 20, 2015
Therapeutic Area Data Standards for Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC)Ronald D Perrone, Jon Neville, Arlene B Chapman, et al.
Kidney International|September 14, 2020
Mineral bone disease in autosomal dominant polycystic kidney diseaseBerenice Gitomer, Renata Pereira, Isidro B Salusky, et al.
Kidney International Reports|December 18, 2019
Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease PatientsMark R Hanudel, Isidro B Salusky, Renata C Pereira, et al.
Kidney International Reports|January 10, 2022
<i>PKD1</i> Compared With <i>PK</i> <i>D2</i> Genotype and Cardiac Hospitalizations in the Halt Progression of Polycystic Kidney Disease StudiesCortney Steele, Zhiying You, Berenice Y Gitomer, et al.
Kidney International|September 26, 2018
CD8<sup>+</sup> T cells modulate autosomal dominant polycystic kidney disease progressionEmily K Kleczko, Kenneth H Marsh, Logan C Tyler, et al.
Pageof 18